SC 13G/A | 2022-02-11 | Chione Ltd | Karyopharm Therapeutics Inc. | 5,000,000 | 6.6% | EDGAR |
SC 13G | 2022-01-27 | BlackRock Inc. | Karyopharm Therapeutics Inc. | 8,918,206 | 11.8% | EDGAR |
SC 13G/A | 2022-01-26 | BlackRock Inc. | Karyopharm Therapeutics Inc. | 8,918,206 | 11.8% | EDGAR |
SC 13G/A | 2021-10-12 | STATE STREET CORP | Karyopharm Therapeutics Inc. | - | 10.6% | EDGAR |
SC 13G/A | 2021-02-17 | Consonance Capital Management LP | Karyopharm Therapeutics Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | Consonance Capital Management LP | Karyopharm Therapeutics Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | Kauffman Michael | Karyopharm Therapeutics Inc. | 4,231,457 | 5.5% | EDGAR |
SC 13G/A | 2021-02-16 | Chione Ltd | Karyopharm Therapeutics Inc. | 5,500,000 | 7.5% | EDGAR |
SC 13G/A | 2021-02-16 | Palo Alto Investors LP | Karyopharm Therapeutics Inc. | 5,267,652 | 7.2% | EDGAR |
SC 13G/A | 2021-02-12 | Avoro Capital Advisors LLC | Karyopharm Therapeutics Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Karyopharm Therapeutics Inc. | 2,465,000 | 3.4% | EDGAR |
SC 13G | 2021-02-11 | STATE STREET CORP | Karyopharm Therapeutics Inc. | - | 7.3% | EDGAR |
SC 13G/A | 2021-01-27 | BlackRock Inc. | Karyopharm Therapeutics Inc. | 7,475,099 | 10.2% | EDGAR |
SC 13G | 2020-12-08 | BlackRock Inc. | Karyopharm Therapeutics Inc. | 7,413,805 | 10.1% | EDGAR |
SC 13G/A | 2020-02-14 | Point72 Asset Management, L.P. | Karyopharm Therapeutics Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | Consonance Capital Management LP | Karyopharm Therapeutics Inc. | 5,521,247 | 8.8% | EDGAR |
SC 13G/A | 2020-02-14 | Ridgeback Capital Investments L.P. | Karyopharm Therapeutics Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | Chione Ltd | Karyopharm Therapeutics Inc. | 5,695,499 | 9.1% | EDGAR |
SC 13G/A | 2020-02-14 | Palo Alto Investors LP | Karyopharm Therapeutics Inc. | 4,595,001 | 7.3% | EDGAR |
SC 13G | 2020-02-14 | Avoro Capital Advisors LLC | Karyopharm Therapeutics Inc. | 5,900,000 | 9.4% | EDGAR |